Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Surg Res ; 228: 253-262, 2018 08.
Article in English | MEDLINE | ID: mdl-29907219

ABSTRACT

BACKGROUND: Tissue necrosis caused by insufficient perfusion is a major complication in flap transfer. This study evaluated whether treatment with cilostazol or hydroalcoholic extract of seeds of Euterpe oleracea Mart. (açaí) protects the transverse rectus abdominis myocutaneous (TRAM) flap against ischemic damage in hamsters. MATERIALS AND METHODS: Fifty-four hamsters were divided into three oral treatment groups: placebo, açaí, or cilostazol. Caudally based, unipedicled TRAM flaps were raised, sutured back, classified into four vascular zones (I-IV), and evaluated for tissue viability, capillary blood flow (CBF), perfused vessel density (PVD), and microvascular flow index (MFI) by orthogonal polarization spectral imaging at three time points: immediately postoperatively (IPO), 24 h postoperatively (24hPO), and 7 d postoperatively (7POD). RESULTS: Comparing to placebo, açaí increased PVD at IPO and açaí and cilostazol increased CBF and PVD at 24hPO in zone I; cilostazol increased CBF, PVD, and MFI at IPO, and CBF at 24hPO in zone II; açaí and cilostazol increased CBF at all time points and PVD and MFI at IPO and 24hPO in zone III; cilostazol increased CBF at IPO and 7POD, açaí increased CBF at 7POD, and both increased PVD and MFI at all time points in zone IV; and açaí and cilostazol increased the percentage of viable area in zones III and IV. CONCLUSIONS: Açaí and cilostazol treatments had a protective effect against ischemic damage to TRAM flaps in hamsters, improving microvascular blood flow and increasing the survival of flap zones contralateral to the vascular pedicle (zones III and IV).


Subject(s)
Cilostazol/pharmacology , Euterpe/chemistry , Microcirculation/drug effects , Myocutaneous Flap/adverse effects , Plant Extracts/pharmacology , Rectus Abdominis/pathology , Animals , Capillaries/drug effects , Cilostazol/therapeutic use , Cricetinae , Disease Models, Animal , Drug Evaluation, Preclinical , Graft Survival/drug effects , Humans , Ischemia/drug therapy , Ischemia/etiology , Ischemia/pathology , Male , Mesocricetus , Myocutaneous Flap/blood supply , Myocutaneous Flap/pathology , Necrosis/drug therapy , Necrosis/etiology , Necrosis/pathology , Plant Extracts/therapeutic use , Rectus Abdominis/drug effects , Rectus Abdominis/transplantation , Seeds/chemistry , Skin/blood supply , Skin/drug effects , Skin/pathology
2.
Clin Exp Hypertens ; 40(8): 721-729, 2018.
Article in English | MEDLINE | ID: mdl-29359965

ABSTRACT

Tempol, a superoxide dismutase-mimetic drug, has been shown to attenuate radical-induced damage, exerting beneficial effects in the animal models of oxidative stress and hypertension. This study evaluated the effect of Tempol on renal structural and functional alterations in two-Kidney, one-Clip hypertensive rats. In this study, young male Wistar rats had the left kidney clipped (2K1C), and sham-operated animals (Sham) were used as controls. Animals received Tempol (1mmol/L in drinking water) or vehicle for 5 weeks. Systolic blood pressure was evaluated once a week. At the end of the experimental protocol, the animals were placed in metabolic cages to collect urine (24h) and then anesthetized with thiopental (70mg/kg i.p.) to collect blood by puncturing the descending aorta for biochemical analysis, and the clipped kidney for morphological and immunohistochemical analyses. The vasodilator effect of Tempol was evaluated in mesenteric arterial bed (MAB) isolated from adult Wistar rats. The chronic treatment with Tempol prevented the development of hypertension and the increased plasma levels of urea, creatinine, and 8-isoprostane in 2K1C animals. Tempol also improved both glomeruli number and kidney volume to normal levels in the 2K1C+Tempol group. In addition, the treatment prevented the increased collagen deposition and immunostaining for renin, caspase-3, and 8-isoprostane in the stenotic kidney of 2K1C animals. Moreover, Tempol induced a dose-dependent vasodilator response in MAB from Wistar rats. These results suggest that Tempol protects the stenotic kidney against chronic ischemic renal injury and prevents renal dysfunction in the 2K1C model, probably through its antioxidant, vasodilator and antihypertensive actions.


Subject(s)
Antioxidants/therapeutic use , Cyclic N-Oxides/therapeutic use , Hypertension/complications , Ischemia/complications , Kidney Diseases/prevention & control , Kidney/blood supply , Animals , Antioxidants/pharmacology , Biomimetic Materials/therapeutic use , Blood Pressure/drug effects , Caspase 3/metabolism , Chronic Disease , Creatinine/blood , Cyclic N-Oxides/pharmacology , Dinoprost/analogs & derivatives , Dinoprost/metabolism , Hypertension/physiopathology , Kidney/metabolism , Kidney Diseases/etiology , Kidney Diseases/physiopathology , Kidney Glomerulus/drug effects , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar , Renin/metabolism , Spin Labels , Superoxide Dismutase , Urea/blood , Vasodilation/drug effects
3.
Clin Exp Hypertens ; 40(2): 126-135, 2018.
Article in English | MEDLINE | ID: mdl-28726518

ABSTRACT

To investigate the systemic and placental oxidant status as well as vascular function in experimental preeclampsia (PE) induced by nitro-L-arginine methyl ester (L-NAME). Fetal parameters and maternal blood pressure, proteinuria, mesenteric arterial bed (MAB) reactivity, and systemic and placental oxidative stress were compared between four groups: pregnant rats receiving L-NAME (60 mg/kg/day, orally) (P + L-NAME) or vehicle (P) from days 13 to 20 of pregnancy and nonpregnant rats receiving L-NAME (NP + L-NAME) or vehicle (NP) during 7 days. L-NAME administration during pregnancy induced some hallmarks of PE, such as hypertension and proteinuria. The P + L-NAME group presented lower weight gain and placental mass as well as reduced number and weight of live fetuses than P group. The vasodilator effect induced by acetylcholine (ACh) and angiotensin II (Ang II) was lower in the perfused MAB from NP + L-NAME and P + L-NAME than in control groups. Otherwise, the nitroglycerine-induced vasodilation and the phenylephrine- and Ang II-induced vasoconstriction were higher in MAB from NP + L-NAME and P + L-NAME groups than in the respective controls. Systemic and placental oxidative damage, assessed by malondialdehyde and carbonyl levels, was increased and activities of the antioxidant enzymes superoxide dismutase and glutathione peroxidase were reduced in P + L-NAME and NP + L-NAME groups compared to controls. The present data suggest that the oxidative stress and reduced bioavailability of nitric oxide may contribute to attenuation of vasodilator responses to ACh and Ang II, and hyperreactivity to Ang II in the mesentery of preeclamptic rat, which may contribute to the increased peripheral vascular resistance and BP, as well as intrauterine growth restriction in L-NAME-induced PE.


Subject(s)
Oxidative Stress , Placenta/metabolism , Pre-Eclampsia/physiopathology , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology , Acetylcholine/pharmacology , Angiotensin II/pharmacology , Animals , Arginine/analogs & derivatives , Blood Pressure/physiology , Enzyme Inhibitors/pharmacology , Female , Fetal Growth Retardation/chemically induced , Fetal Growth Retardation/physiopathology , Glutathione Peroxidase/metabolism , Hypertension/physiopathology , Malondialdehyde/metabolism , Mesentery/blood supply , NG-Nitroarginine Methyl Ester , Nitric Oxide/metabolism , Nitric Oxide Synthase , Nitroglycerin/pharmacology , Oxidative Stress/drug effects , Phenylephrine/pharmacology , Pre-Eclampsia/chemically induced , Pregnancy , Protein Carbonylation/drug effects , Rats , Superoxide Dismutase/metabolism , Vasoconstriction/drug effects , Vasodilation/drug effects
4.
J Cardiovasc Pharmacol ; 68(1): 19-26, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26657713

ABSTRACT

Despite being used for a long time as food and beverage by Brazilian people who live on the Amazon bay, only in the beginning of this century, açaí berries have been the object of scientific research. Açaí berries are rich in polyphenols that probably explains its versatile pharmacological actions and huge consumption, not only in Brazil but also in Europe and United States. In this review, not all but some pharmacological aspects of açaí berries are analyzed. Chemical and pharmacological differences between extracts obtained from the skin and seed of açaí are considered. Polyphenols from the seed of açaí increase endothelial nitric oxide production leading to endothelium-dependent relaxation, reduce reactive oxygen species and regulate key targets associated with lipid metabolism in different conditions such as hypertension, renal failure, and metabolic syndrome. We review the novel mechanisms of actions of açaí on different targets which could trigger the health benefits of açaí such as antioxidant, vasodilator, antihypertensive, cardioprotector, renal protector, antidyslipidemic, antiobesity, and antidiabetic effects in cardiovascular and metabolic disturbances.


Subject(s)
Cardiovascular Agents/therapeutic use , Cardiovascular Diseases/prevention & control , Euterpe/chemistry , Metabolic Diseases/prevention & control , Phytochemicals/therapeutic use , Plant Extracts/therapeutic use , Animals , Cardiovascular Agents/isolation & purification , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/physiopathology , Fruit/chemistry , Humans , Metabolic Diseases/metabolism , Metabolic Diseases/physiopathology , Phytochemicals/isolation & purification , Phytotherapy , Plant Extracts/isolation & purification , Plants, Medicinal
5.
PLoS One ; 10(12): e0143721, 2015.
Article in English | MEDLINE | ID: mdl-26630290

ABSTRACT

The aim of this study was to investigate the effect of a polyphenol-rich Açaí seed extract (ASE, 300 mg/kg-1d-1) on adiposity and hepatic steatosis in mice that were fed a high-fat (HF) diet and its underlying mechanisms based on hepatic lipid metabolism and oxidative stress. Four groups were studied: C57BL/6 mice that were fed with standard diet (10% fat, Control), 10% fat + ASE (ASE), 60% fat (HF), and 60% fat + ASE (HF + ASE) for 12 weeks. We evaluated the food intake, body weight gain, serum glucose and lipid profile, hepatic cholesterol and triacyglycerol (TG), hepatic expression of pAMPK, lipogenic proteins (SREBP-1c, pACC, ACC, HMG-CoA reductase) and cholesterol excretion transporters, ABCG5 and ABCG8. We also evaluated the steatosis in liver sections and oxidative stress. ASE reduced body weight gain, food intake, glucose levels, accumulation of cholesterol and TG in the liver, which was associated with a reduction of hepatic steatosis. The increased expressions of SREBP-1c and HMG-CoA reductase and reduced expressions of pAMPK and pACC/ACC in HF group were antagonized by ASE. The ABCG5 and ABCG8 transporters expressions were increased by the extract. The antioxidant effect of ASE was demonstrated in liver of HF mice by restoration of SOD, CAT and GPx activities and reduction of the increased levels of malondialdehyde and protein carbonylation. In conclusion, ASE substantially reduced the obesity and hepatic steatosis induced by HF diet by reducing lipogenesis, increasing cholesterol excretion and improving oxidative stress in the liver, providing a nutritional resource for prevention of obesity-related adiposity and hepatic steatosis.


Subject(s)
Cholesterol/metabolism , Euterpe/chemistry , Lipogenesis/drug effects , Liver/drug effects , Non-alcoholic Fatty Liver Disease/prevention & control , Obesity/prevention & control , Polyphenols/pharmacology , Adipokines/metabolism , Adipose Tissue/drug effects , Adipose Tissue/pathology , Animals , Antioxidants/metabolism , Body Weight/drug effects , Cholesterol/biosynthesis , Diet, High-Fat/adverse effects , Eating/drug effects , Fatty Acids/biosynthesis , Gene Expression Regulation/drug effects , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease/etiology , Non-alcoholic Fatty Liver Disease/metabolism , Non-alcoholic Fatty Liver Disease/pathology , Obesity/etiology , Obesity/metabolism , Obesity/pathology , Organ Size/drug effects , Oxidative Stress/drug effects , Seeds/chemistry
6.
BMC Complement Altern Med ; 15: 208, 2015 Jul 02.
Article in English | MEDLINE | ID: mdl-26134625

ABSTRACT

BACKGROUND: Plants rich in flavonoids, such as açaí (Euterpe oleraceae Mart.), can induce antinociception in experimental animals. Here, we tested an extract obtained from the stones of açaí fruits (açaí stone extract, ASE), a native plant from the Amazon region of Brazil, in models of acute/inflammatory and chronic pain. METHODS: Antinociceptive effects of ASE were evaluated in the hot plate, formalin, acetic acid writhing, carrageenan, and neuropathic pain models, as well as in thermal hyperalgesia and mechanical allodynia models induced by spinal nerve ligation. Antinociceptive activities were modulated by the administration of cholinergic, adrenergic, opioid, and L-arginine-NO antagonists. RESULTS: Oral administration of ASE (30, 100, or 300 mg.kg(-1)) dose-dependently reduced nociceptive responses to acute/inflammatory pain in mice, including thermal hyperalgesia, acetic acid-induced writhing, and carrageenan-induced thermal hyperalgesia. Moreover, ASE reduced the neurogenic and inflammatory phases after intraplantar injection of formalin in mice. The antinociceptive effect of ASE (100 mg · kg(-1)) in a hot plate protocol, was inhibited by pre-treatment with naloxone (1 mg · kg(-1)), atropine (2 mg · kg(-1)), yohimbine (5 mg · kg(-1)), or L-NAME (30 mg · kg(-1)). Furthermore, ASE prevented chronic pain in a rat spinal nerve ligation model, including thermal hyperalgesia and mechanical allodynia. CONCLUSION: ASE showed significant antinociceptive effect via a multifactorial mechanism of action, indicating that the extract may be useful in the development of new analgesic drugs.


Subject(s)
Analgesics , Euterpe/chemistry , Neuralgia/drug therapy , Plant Extracts , Analgesics/chemistry , Analgesics/pharmacology , Analgesics/therapeutic use , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Inflammation/drug therapy , Mice , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats
7.
BMC Complement Altern Med ; 14: 227, 2014 Jul 08.
Article in English | MEDLINE | ID: mdl-25000822

ABSTRACT

BACKGROUND: This study was designed to evaluate the cardioprotective effects of Euterpe oleracea Mart., popularly known as "açaí", on rats subjected to myocardial infarction (MI). METHODS: Hydroalcoholic extracts of açaí were obtained from a decoction of the seeds. Two male Wistar rat groups were delineated: 1) the sham-operated group (control, n = 6), with no surgical amendment, and 2) the MI group (n = 12), in which the anterior descendent coronary artery was occluded during surgery. MI group was divided into two subgroups, in which rats were either treated with hydroalcoholic extract of Euterpe oleracea seeds (100 mg/kg/day p.o.) or received no treatment. Treatment began on the day of surgery, and lasted 4 weeks. Subsequently, rats were subject to an exercise test protocol, hemodynamic evaluation, and histological analysis of the left ventricle. Groups were compared using one-way analysis of variance (ANOVA), followed by Dunnett's test. RESULTS: The total running distance of sham rats was 1339.0 ± 276.6 m, MI rats was 177.6 ± 15.8 m (P < 0.05), and MI-açaí rats was 969.9 ± 362.2 m. Systolic arterial pressure was significantly decreased in MI rats (86.88 ± 4.62 mmHg) compared to sham rats (115.30 ± 7.24 mmHg; P < 0.05). Açaí treatment prevented a reduction in systolic arterial pressure (130.00 ± 8.16 mmHg) compared to MI rats (P < 0.05). Left ventricular (LV) end-diastolic pressure was significantly augmented in MI rats (17.62 ± 1.21 mmHg) compared to sham rats (4.15 ± 1.60 mmHg; P < 0.05), but was 3.69 ± 2.69 mmHg in açaí-treated rats (P < 0.05 vs. MI). The LV relaxation rate (-dp/dt) was reduced in MI rats compared to the sham group, whereas açaí treatment prevented this reduction. Açaí treatment prevented cardiac hypertrophy and LV fibrosis in MI rats. CONCLUSIONS: Euterpe oleracea treatment of MI rats prevented the development of exercise intolerance, cardiac hypertrophy, fibrosis, and dysfunction.


Subject(s)
Arecaceae/chemistry , Exercise Tolerance/drug effects , Myocardial Infarction/drug therapy , Plant Extracts/pharmacology , Administration, Oral , Animals , Cardiomegaly/drug therapy , Hemodynamics/drug effects , Male , Myocardial Infarction/physiopathology , Plant Extracts/chemistry , Rats , Rats, Wistar , Seeds/chemistry , Ventricular Dysfunction, Left/drug therapy
8.
Fundam Clin Pharmacol ; 28(1): 104-13, 2014 Feb.
Article in English | MEDLINE | ID: mdl-22924641

ABSTRACT

Dexmedetomidine (DEX) is a α2 -adrenoceptor (α2 -AR) agonist used as an anesthetic adjuvant and as sedative in critical care settings. Typically, α2 -AR agonists release nitric oxide (NO) and subsequently activate NO-GMPc pathway and have been implicated with antinociception. In this study, we investigate the pharmacological mechanisms involved in the antinociceptive effects of DEX, using an acetic acid-induced writhing assay in mice. Saline or DEX (1, 2, 5, or 10 µg/kg) was intravenously injected 5 min before ip administration of acetic acid and the resulting abdominal constrictions were then counted for 10 min. To investigate the possible mechanisms related to antinociceptive effect of DEX (10 µg/kg), the animals were also pretreated with one of the following drugs: 7-nitroindazole (7-NI; 30 mg/kg ip); 1H-[1,2,4] oxadiazole [4,3-a] quinoxaline-1-one (ODQ; 2.5 mg/kg, ip); yohimbine (YOH; 1 mg/kg, ip); atropine (ATRO; 2 mg/kg, ip); glibenclamide (GLIB; 1 mg/kg, i.p.) and naloxone (NAL; 0.2 mg/kg, ip). A rotarod and open-field performance test were performed with DEX at 10 µg/kg dose. DEX demonstrated its potent antinociceptive effect in a dose-dependent manner. The pretreatment with 7-NI, ODQ, GLIB, ATRO, and YOH significantly reduced the antinociceptive affects of DEX. However, NAL showed no effecting DEX-induced antinociception. The rotarod and open-field tests confirmed there is no detectable sedation or even significant motor impairment with DEX at 10 µg/kg dose. Our results suggest that the α2 -AR and NO-GMPc pathways play important roles in the systemic antinociceptive effect of DEX in a murine model of inflammatory pain. Furthermore, the antinociceptive effect exerted by DEX appears to be dependent on KATP channels, independent of opioid receptor activity.


Subject(s)
Analgesics/pharmacology , Dexmedetomidine/pharmacology , Pain/drug therapy , Animals , Mice , Nitric Oxide/metabolism , Pain/metabolism , Pain Measurement/methods , Receptors, Adrenergic, alpha-2/metabolism
9.
J Nutr Biochem ; 24(12): 2119-26, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24183306

ABSTRACT

Maternal overnutrition during suckling period is associated with increased risk of metabolic disorders in the offspring. We aimed to assess the effect of Vitis vinifera L. grape skin extract (ACH09) on cardiovascular and metabolic disorders in adult male offspring of rats fed a high-fat (HF) diet during lactation. Four groups of female rats were fed: control diet (7% fat), ACH09 (7% fat plus 200 mg kg(-1) d(-1) ACH09 orally), HF (24% fat), and HF+ACH09 (24% fat plus 200 mg kg(-1) d(-1) ACH09 orally) during lactation. After weaning, all male offspring were fed a control diet and sacrificed at 90 or 180 days old. Systolic blood pressure was increased in adult offspring of HF-fed dams and ACH09 prevented the hypertension. Increased adiposity, plasma triglyceride, glucose levels and insulin resistance were observed in offspring from both ages, and those changes were reversed by ACH09. Expression of insulin cascade proteins IRS-1, AKT and GLUT4 in the soleus muscle was reduced in the HF group of both ages and increased by ACH09. The plasma oxidative damage assessed by malondialdehyde levels was increased, and nitrite levels decreased in the HF group of both ages, which were reversed by ACH09. In addition, ACH09 restored the decreased plasma and mesenteric arteries antioxidant activities of superoxide dismutase, catalase and glutathione peroxidase in the HF group. In conclusion, the treatment of HF-fed dams during lactation with ACH09 provides protection from later-life hypertension, body weight gain, insulin resistance and oxidative stress. The protective effect ACH09 may involve NO synthesis, antioxidant action and activation of insulin-signaling pathways.


Subject(s)
Diet, High-Fat/adverse effects , Maternal Nutritional Physiological Phenomena , Plant Extracts/pharmacology , Vitis/chemistry , Adiposity , Animals , Blood Pressure/drug effects , Cardiovascular Diseases/prevention & control , Catalase/blood , Female , Fruit/chemistry , Glucose Transporter Type 4/genetics , Glucose Transporter Type 4/metabolism , Glutathione Peroxidase/blood , Insulin/blood , Insulin Receptor Substrate Proteins/genetics , Insulin Receptor Substrate Proteins/metabolism , Insulin Resistance , Lactation , Male , Malondialdehyde/blood , Metabolic Diseases/prevention & control , Oncogene Protein v-akt/genetics , Oncogene Protein v-akt/metabolism , Oxidative Stress/drug effects , Pregnancy , Rats , Rats, Wistar , Superoxide Dismutase/blood , Triglycerides/blood , Weight Gain/drug effects
10.
Hypertens Res ; 36(9): 783-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23575380

ABSTRACT

Pre-eclampsia (PE), a syndrome of pregnancy-induced hypertension, continues to be a leading cause of maternal and fetal morbidity and mortality. The aim of this study was to investigate whether changes in oxidative status are correlated with alterations in the L-arginine-nitric oxide pathway and platelet aggregation in PE. Plasma and platelets from women with PE (n=24) or normotensive pregnancy (NP, n=27) recruited in the third trimester of gestation were used to measure oxidative damage assessed by protein carbonyl content, antioxidant activities of superoxide dismutase (SOD), catalase (CAT) and nitrite levels. Transport of L-[(3)H]-arginine, as well as the activities of the nitric oxide (NO) synthase (eNOS and inducible NO synthase (iNOS)) and platelet aggregation, were also evaluated. Plasma nitrite levels and the activities of SOD and CAT were reduced in PE (5.2±2.7, 3.4±0.8, 0.3±0.4, respectively, P<0.05) compared with NP (8.7±2.3, 6.7±3.1, 1.0±0.5, respectively), whereas protein carbonyl content and L-arginine levels were not significantly different between PE and NP groups. In platelets, L-arginine transport was reduced in PE (19.2±10.5, P<0.05) compared with NP (62.0±31.1), whereas the NOS activity, eNOS and iNOS expression, nitrite levels and platelet aggregation were unaffected. Protein carbonyl content was increased, and CAT activity was reduced in platelets from PE (0.03±0.02, 0.55±0.30, respectively, P<0.05), compared with NP (0.005±0.005, 1.01±0.36, respectively). The data suggest that a systemic impairment of antioxidant defense mechanisms is associated with decreased plasma nitrite levels, which may contribute to hypertension in PE. Oxidative stress may contribute to the reduced influx of L-arginine in platelets. Compensatory mechanisms may contribute to the maintenance of NO production and its modulatory role on platelet function.


Subject(s)
Arginine/metabolism , Blood Platelets/metabolism , Nitric Oxide/metabolism , Oxidative Stress/physiology , Pre-Eclampsia/metabolism , Adolescent , Adult , Arginine/blood , Catalase/metabolism , Female , Humans , Nitric Oxide/blood , Platelet Aggregation/physiology , Pre-Eclampsia/blood , Pregnancy , Signal Transduction/physiology , Superoxide Dismutase/metabolism
11.
Am J Hypertens ; 25(4): 498-504, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22258331

ABSTRACT

BACKGROUND: The purpose of this study was to investigate the contribution of renin-angiotensin system (RAS) and oxidative status on the maternal cardiovascular regulation at the end of pregnancy in normotensive and spontaneously hypertensive rats (SHR). METHODS: Blood pressure (BP), mesenteric arterial bed (MAB) reactivity, mesenteric oxidative damage, protein expression, and antioxidant activities were compared between four groups: SHR (SHR-P) and normotensive Wistar controls (W-P) in the 20th day of pregnancy or age-matched nonpregnant rats (SHR-NP and W-NP). RESULTS: BP in W-P and SHR-P was reduced at the end of pregnancy. The vasodilator effects of angiotensin II (Ang II) and angiotensin 1-7 (Ang-(1-7)) were higher in SHR-P than in other groups. Endothelial nitric oxide synthase (eNOS) expression was increased in W-P and SHR-P compared to nonpregnant groups. Angiotensin-converting enzyme (ACE) and AT(1) receptor expressions were increased in SHR-NP compared to normotensive groups and pregnancy reduced their expressions in SHR. No difference was observed in AT(2) receptor expression among the groups. ACE2 expression was higher in hypertensive than normotensive groups. The levels of thiobarbituric acid-reactive substances (TBARS) were reduced in pregnant compared to nonpregnant groups. Superoxide dismutase (SOD) activity was reduced in SHR-P compared to SHR-NP. However, pregnancy increased catalase (CAT) and glutathione peroxidase (GPx) activities in normotensive rats and SHR, respectively. CONCLUSIONS: The results suggest that the reduction of BP to normal values at the end of pregnancy in SHR may be related to an increased NO production and vasorelaxation to Ang II and Ang-(1-7) associated with decreased expression of vascular ACE and AT(1) receptors and oxidative status.


Subject(s)
Hypertension/physiopathology , Pregnancy Complications, Cardiovascular/physiopathology , Pregnancy/physiology , Renin-Angiotensin System/physiology , Angiotensin I/pharmacology , Angiotensin II/pharmacology , Animals , Blood Pressure/physiology , Female , Nitric Oxide Synthase Type III/metabolism , Peptide Fragments/pharmacology , Peptidyl-Dipeptidase A/metabolism , Rats , Rats, Inbred SHR , Rats, Wistar , Receptor, Angiotensin, Type 1/metabolism , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
12.
Am J Hypertens ; 22(12): 1242-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19779472

ABSTRACT

BACKGROUND: Two-kidney-one-clip (2K-1C) rats develop renovascular hypertension associated with endothelial dysfunction and elevated levels of oxidative stress. The role of oxidative damage is unknown in vascular dysfunction coupled with 2K-1C hypertension. The aims of this study were to evaluate the effects of chronic treatment with a superoxide dismutase (SOD) mimetic (tempol) and an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase (apocynin) on the development of hypertension, endothelial dysfunction, and oxidative damage in 2K-1C rats. METHODS: 2K-1C rats and sham-operated rats were treated with tempol or apocynin for 40 days, while the corresponding nontreated groups received tap water. Blood pressure (BP), mesenteric arterial reactivity, plasma and mesentery oxidative damage, mesenteric protein expression, and antioxidant activities were compared among the four groups. RESULTS: Chronic treatment with tempol (1 mmol/l) or apocynin (33 microg/kg/day) impaired the development of hypertension in 2K-1C rats and did not change the BP in control animals. The reduction in vasodilatory effect induced by acetylcholine (ACh) in the mesenteric arterial beds (MABs) of 2K-1C rats was restored by tempol and apocynin. Plasma and mesentery levels of malondialdehyde (MDA) were higher in 2K-1C rats, and these levels were significantly reduced by the administration of tempol and apocynin. Mesenteric SOD activity and expression were higher in 2K-1C rats than in the controls, and treatment with tempol resulted in a reduction in SOD activity. CONCLUSIONS: The data suggest that a compromised mechanism of antioxidant defense and an increase in oxidative damage contribute to the development of hypertension and associated vascular dysfunction in 2K-1C rats, and that tempol and apocynin prevent these effects.


Subject(s)
Acetophenones/therapeutic use , Antioxidants/therapeutic use , Cyclic N-Oxides/therapeutic use , Hypertension, Renovascular/drug therapy , Hypertension, Renovascular/prevention & control , Animals , Blood Pressure/drug effects , Catalase/metabolism , Hypertension, Renovascular/physiopathology , Male , Rats , Rats, Wistar , Spin Labels , Superoxide Dismutase/metabolism
13.
Cell Mol Biol (Noisy-le-grand) ; 48(5): 517-20, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12146706

ABSTRACT

The use of natural products as medicines is growing in the world. The rutin, a compound isolated from Ruta graveolens, is a flavonoid, which has been suggested to have antioxidant properties and to reduce the triacylglycerol levels. In this study, plasmid desoxyribonucleic acid (DNA) was exposed to rutin (0.33, 10, 20, 30 microg/ml) in presence of stannous chloride (SnCl2), a reducing agent widely used to obtain radiopharmaceuticals labeled with technetium-99m. Samples of the plasmid DNA were analyzed through agarose gel electrophoresis. E. coli AB1157 culture was also incubated with rutin (3, 30, 50, 100 microg/ml) and the survival fractions were calculated. The results show that the rutin, in these concentrations, is not capable of: i/ damaging the DNA, ii/ protecting the DNA from the SnCl2 redox action, and iii/ inactivating the E. coli AB1157 culture. The analysis of our data indicates that rutin do not present toxic activity in the evaluated systems.


Subject(s)
Escherichia coli/drug effects , Plasmids/drug effects , Rutin/pharmacology , Antioxidants/pharmacology , DNA Damage/drug effects , Electrophoretic Mobility Shift Assay , Escherichia coli/growth & development , Ruta/chemistry , Tin Compounds
SELECTION OF CITATIONS
SEARCH DETAIL
...